{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:09:05Z","timestamp":1789715345986,"version":"4.0.1"},"reference-count":26,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":203,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:p> <jats:bold>Combined use of novel epithelial (MOC\u201031) and mesothelial (HBME\u20101) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura<\/jats:bold> <\/jats:p><jats:p> <jats:italic>Aims<\/jats:italic>: To determine the value of immunohistochemistry in differentiation of malignant pleural mesothelioma from carcinoma in a pleural biopsy we optimized a double panel of MOC\u201031 and HBME\u20101 and compared the results with others from the literature.<\/jats:p><jats:p> <jats:italic>Methods and results<\/jats:italic>: A multi\u2010antibody panel was applied to biopsy samples from 44 cases of malignant pleural mesothelioma and 23 cases of carcinoma metastatic to the pleura. We used monoclonal antibodies against keratins, epithelial membrane antigen (EMA), epithelial antigen Ber\u2010EP4, carcinoembryonic antigen (CEA), tumour\u2010associated glycoprotein (B72.3), LeuM1, vimentin, desmin, epithelial related antigen (MOC\u201031) and mesothelial cell (HBME\u20101). Positivity for MOC\u201031 and Ber\u2010EP4 was found to have the highest nosologic sensitivity (94.1% and 84.6%, respectively) and specificity (86.3% both antibodies) for carcinoma. Positive staining for HBME\u20101 and vimentin had the highest sensitivity (90.9% and 100%, respectively) and specificity (91.3% and 60%, respectively) for mesothelioma. A two\u2010marker antibody panel with HBME\u20101 and MOC\u201031 was the most efficient for the distinction between carcinoma and malignant pleural mesothelioma.<\/jats:p><jats:p> <jats:italic>Conclusion<\/jats:italic>: A combination of MOC\u201031 (an anti\u2010 epithelial marker) and HBME\u20101 (an anti\u2010mesothelial marker) has a diagnostic efficiency of 76.1% for the distinction between carcinoma and mesothelioma in pleura.<\/jats:p>","DOI":"10.1046\/j.1365-2559.2001.01157.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T00:11:53Z","timestamp":1047427913000},"page":"528-534","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Combined use of novel epithelial (MOC\u201031) and mesothelial (HBME\u20101) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura"],"prefix":"10.1111","volume":"38","author":[{"given":"C","family":"Gonz\u00e1lez\u2010Lois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ballest\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M T","family":"Sotelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"L\u00f3pez\u2010R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D","family":"Garc\u00eda\u2010Prats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Villena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/112.1.75"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1998.00405.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199712000-00001"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/29.4.6166661"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/34.8.2426335"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197906)43:6<2288::AID-CNCR2820430619>3.0.CO;2-N"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90008-3"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199712000-00003"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199712000-00002"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1996.d01-562.x"},{"key":"e_1_2_5_12_2","first-page":"115","article-title":"HBME\u20101: a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft tissue and bone tumors","volume":"3","author":"Miettinen M","year":"1995","journal-title":"Appl. Immunohistochem."},{"key":"e_1_2_5_13_2","first-page":"162A","article-title":"Mesothelioma vs adenocarcinoma: diagnostic utility of HBME\u20101","volume":"74","author":"Savera AT","year":"1996","journal-title":"Lab. Invest."},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1996.tb01393.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.50.10.859"},{"key":"e_1_2_5_16_2","first-page":"152A","article-title":"HBME\u20101 aids in distinguishing mesotheliomas and adenocarcinomas of the lung and breast","volume":"8","author":"Renshaw AA","year":"1995","journal-title":"Mod. Pathol."},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2000.00770.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711650209"},{"key":"e_1_2_5_19_2","first-page":"265","article-title":"Immunocytology of body cavity fluids. MOC\u201031 a monoclonal antibody discriminating between mesothelial and epithelial cells","volume":"118","author":"Ruitenbeek T","year":"1994","journal-title":"Arch. Pathol. Lab. Med."},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.48.7.626"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1998.00349.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000333902"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/109.1.85"},{"key":"e_1_2_5_24_2","first-page":"716","article-title":"Anti\u2010MOC\u201031: a potential addition to the pulmonary adenocarcinoma versus mesothelioma immunohistochemistry panel","volume":"10","author":"Sosolick RC","year":"1997","journal-title":"Mod. Pathol."},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(93)90080-Z"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1994.tb04873.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1997.tb05099.x"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2559.2001.01157.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2559.2001.01157.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2559.2001.01157.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T10:42:43Z","timestamp":1697625763000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2559.2001.01157.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1046\/j.1365-2559.2001.01157.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2559.2001.01157.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"2001-12-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}